A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
Recruiting
Observational Study
COVID-19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
67 (estimated)
Sponsor
Mayo Clinic · Other
Who this trial is looking for
This trial is looking for people who have had a serious COVID-19 infection and are experiencing long-term effects, like shortness of breath and fatigue. It also includes individuals who had mild COVID-19 without hospitalization for comparison.
Are You a Good Fit for This Trial?
You may be able to join if
I am at least 18 years old.
I have had COVID-19 confirmed by a PCR test.
I was hospitalized for COVID-19.
I did not have pre-existing lung disease.
I need supplemental oxygen during my COVID-19 hospitalization.
I had a mild COVID-19 infection that did not require hospitalization.
You may not be able to join if
I cannot provide informed consent.
I have a history of interstitial lung disease or chronic lung disease.
I am currently smoking or vaping.
I am taking immunosuppressive medication.
I have a history of chemotherapy or radiation therapy in the last two years.
I am pregnant.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
For the Sequelae Group
* Age ≥18 years at screening, PCR confirmed COVID19 illness (+PCR defines day 0 of illness), hospitalization for COVID-19, absence of pre-existing history of interstitial lung disease, or significant other lung disease.
* Severity of illness will be categ…
Inclusion Criteria:
For the Sequelae Group
* Age ≥18 years at screening, PCR confirmed COVID19 illness (+PCR defines day 0 of illness), hospitalization for COVID-19, absence of pre-existing history of interstitial lung disease, or significant other lung disease.
* Severity of illness will be categorized as moderate disease (supplemental oxygen need 1-8L at any time during hospitalization), severe disease (need for high flow oxygen delivery ≥8L at any time during hospitalization) and critical illness (need for ICU admission or mechanical ventilation).
Control Recovery Group
* Age ≥18 years at screening
* PCR confirmed COVID-19 cases who had nonsymptomatic or mild acute infection that do not require hospitalization 7,48,49
* Absence of pre-existing history of interstitial lung disease, or significant other lung disease, absence of any ongoing respiratory and systemic symptoms.
Exclusion Criteria:
* Inability to provide informed consent, evidence of pre-existing interstitial lung disease or chronic lung disease;
* Active cigarette smoking, vaping or other inhalation use.
* Immunocompromised host status due to ongoing therapy with methotrexate, CellCept, azathioprine, rituximab, cyclophosphamide or other biologic agents;
* \> 20 pack year smoking history.
* History of chemotherapy or radiation therapy in the last two years; and pregnancy.
Contacts
No contact information available.
What are you hoping to find?
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.